We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$204M
2
TSM icon
TSMC
TSM
+$94.9M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$58M
4
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$23M
5
VNQ icon
Vanguard Real Estate ETF
VNQ
+$17.9M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$52.8M
2
AAPL icon
Apple
AAPL
+$32.5M
3
MSFT icon
Microsoft
MSFT
+$16.2M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$14.5M
5
DIS icon
Walt Disney
DIS
+$14.2M

Sector Composition

Rank Sector Weight
1 Technology 21.24%
2 Consumer Discretionary 7.38%
3 Financials 6.38%
4 Healthcare 5.93%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MPU icon
4376
Mega Matrix
MPU
$13.9M
$10K ﹤0.01%
6,586
+1,999
+44% +$3.19K
MTNB icon
4377
Matinas BioPharma
MTNB
$1.43M
$10K ﹤0.01%
425
+100
+31% +$2.53K
NGD
4378
DELISTED
New Gold Inc
NGD
$10K ﹤0.01%
8,872
-37,187
-81% -$37.9K
NN icon
4379
NextNav
NN
$3.19B
$10K ﹤0.01%
4,880
-1,289
-21% -$3.45K
NPK icon
4380
National Presto Industries
NPK
$999M
$10K ﹤0.01%
139
-204
-59% -$14.9K
NRXP icon
4381
NRX Pharmaceuticals
NRXP
$137M
$10K ﹤0.01%
1,484
+874
+143% +$8.86K
NSYS icon
4382
Nortech Systems
NSYS
$34.7M
$10K ﹤0.01%
891
+69
+8% +$925
NTRB icon
4383
Nutriband
NTRB
$39.5M
$10K ﹤0.01%
3,120
+1,501
+93% +$5.53K
NVDL icon
4384
GraniteShares ETF Trust GraniteShares 2x Long NVDA Daily ETF
NVDL
$3.87B
$10K ﹤0.01%
+3,834
New +$7.09K
NXGL icon
4385
NexGel
NXGL
$4.7M
$10K ﹤0.01%
8,154
-123
-1% -$178
NYAX
4386
Nayax
NYAX
$1.94B
$10K ﹤0.01%
553
+172
+45% +$3.34K
ONL
4387
Orion Office REIT
ONL
$164M
$10K ﹤0.01%
1,509
+104
+7% +$845
OPFI icon
4388
OppFi
OPFI
$613M
$10K ﹤0.01%
5,029
+2
+0% +$4
OWLT icon
4389
Owlet
OWLT
$185M
$10K ﹤0.01%
2,239
+1,293
+137% +$7.66K
PAM icon
4390
Pampa Energía
PAM
$4.2B
$10K ﹤0.01%
300
– –
PCB icon
4391
PCB Bancorp
PCB
$400M
$10K ﹤0.01%
667
+203
+44% +$3.5K
PRAX icon
4392
Praxis Precision Medicines
PRAX
$10B
$10K ﹤0.01%
821
-952
-54% -$40.2K
PRPL icon
4393
Purple Innovation
PRPL
$28.4M
$10K ﹤0.01%
144
-61
-30% -$6.8K
PUK icon
4394
Prudential
PUK
$34.6B
$10K ﹤0.01%
358
+270
+307% +$8.11K
PULM icon
4395
Pulmatrix
PULM
$5.73M
$10K ﹤0.01%
3,547
+142
+4% +$514
QUAD icon
4396
Quad
QUAD
$503M
$10K ﹤0.01%
2,403
+404
+20% +$1.78K
LNAI
4397
Lunai Bioworks
LNAI
$9.79M
$10K ﹤0.01%
132
+36
+38% +$3.17K
RGLS
4398
DELISTED
Regulus Therapeutics
RGLS
$10K ﹤0.01%
11,831
+4,829
+69% +$6.38K
RGS icon
4399
Regis Corp
RGS
$71.2M
$10K ﹤0.01%
440
+415
+1,660% +$11.5K
RLMD icon
4400
Relmada Therapeutics
RLMD
$507M
$10K ﹤0.01%
4,619
-19,422
-81% -$67K
174 175
176
177 178

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.